Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, November 8, 2012 - HPC, Cord Blood BLA 125432

 

Submission Type: BLA    Submission ID: 125432/0    Office: OCTGT
Product:
HPC, Cord Blood
Applicant:
LifeSouth Community Blood Centers, Inc.
Telecon Date/Time: 08-Nov-2012 12:00 AM        Initiated by FDA? Yes
Telephone Number:
Communication Categorie(s):
1. Advice
 
Author: MOHAMMED HEIDARAN
Telecon Summary:
Advice was given about the batch record
FDA Participants: None
Non-FDA Participants: None
Trans-BLA Group: No
 
Related STNs: None
Related PMCs: None
Telecon Body:
I spoke to Jill Evan VP of Quality at LifeSouth about the batch record. I emphasized the importance of including (1) all critical steps in the batch record; (2) all calculations for addition of HES or DMSO for example to the cord blood during the processing steps; and (3) Acceptance criteria for all critical process parameters such as a) time of cord blood collection to cryopreservation; b) time of DMSO addition to the processed cord blood to cryopreservation; c) predetermined time and temperature for cryopreservation (freezing acceptance criteria) etc. The sponsor agreed to send a revised batch record for further discussion.  

Page Last Updated: 07/09/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English